GlassScriptPhysician profile
Maggie Smith
NPI 1134584295
$5,471.35
in general payments reported to CMS, 2019-2025
38 companies · $1,106 in 2025
The $1,106 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,371 · 2022: $1,070 · 2023: $1,070 · 2024: $854 · 2025: $1,106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,029.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,029.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $979.53 | 2021-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $797.61 | 2021-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $784.81 | 2021-2025 | |
| Lilly USA, LLC | $451.86 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $337.11 | 2021-2025 | Evenity, Prolia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $227.88 | 2021-2025 | Xifaxan, Trulance, Cycloset |
| Takeda Pharmaceuticals U.S.A., INC. | $225.83 | 2021-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $165.42 | 2021-2023 | Xarelto |
| Corium, LLC | $110.47 | 2023-2025 | Azstarys |
| Esperion Therapeutics, INC. | $110.44 | 2021-2025 | Nexletol |
| Merck Sharp & Dohme LLC | $95.42 | 2021-2023 | Dificid |
| Abbott Laboratories | $92.04 | 2021-2024 | Freestyle Libre |
| Axsome Therapeutics, INC. | $90.54 | 2023-2025 | Auvelity |
| Pfizer INC. | $87.49 | 2021-2024 | |
| Antares Pharma, INC. | $79.36 | 2024-2025 | Xyosted |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maggie Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.